Nicholaas Honig

Blog Post by Nicholaas Honig

Quality, Rigor, and Transparency: The RWE Imperative

Over the past year, news stories have focused on high-profile missteps or fraud in the ...

FDA releases draft guidance on non-interventional studies for drug and biological products

The Food and Drug Administration (FDA) continues to advance its RWE Program, this time ...